Assistant Years Experience

Eun Ok Kim

******@*****.***

415-***-****

PROFILE

Research Scientist with six years experience in biotechnology industry with

companies focused on oncology, inflammatory, and metabolic areas. Well

rounded contributor in the cellular and molecular biology aspect of

projects with significant expertise in cell-based assays/analysis. Focused,

flexible, and reliable multi-tasker with reputation for producing high

quality work before deadlines and under pressure. Organized planner with

excellent communication skills. Established strong leadership with

supervisor(s).

PROFESSIONAL EXPERIENCE

Exelixis, Inc, South San Francisco, CA

2005-2011

Assistant Research Scientist I-II

. Supported lead validation/optimization/post-DC projects as part of

Core Assay group in Molecular & Cellular Pharmacology Department.

Performed cell based assays including proliferation, cytotoxicity,

apoptosis, viability, and other ELISA assays to characterize HTS

compounds for SAR.

. Performed mechanistic assays, combination studies, low serum studies,

cell line profiling, Western Blot, assay development, and assay

optimization.

. Analyzed data, created reports, and presentations using Microsoft

Office (Word, EXCEL, Outlook, PowerPoint), CalcuSyn, Prism, ImageQuant,

ActivityBase, and Odyssey programs.

. Worked with liquid handling automation (PlateMate Plus, BioMek FX,

BioMek2000, Serial Mate, MAP-C, Bio-Tek Washers, Multi-drop Combi) and

robotic systems (Plate Crane, RapidStak) for high through-put

screening.

. Performed cell culture work by maintaining, harvesting, and seeding

different adherent, suspension, and primary mammalian cell lines.

. Trained new employee on profiles of assays used in the Core Assay,

data analysis processes and report creation.

. Maintained laboratory notebook in complete, consistent concise manner

in accordance with company intellectual property policies and

practices.

Associate Research Scientist I

. Performed cell cycle analysis (Guava, Cellomics), neutrophil

degranulation assay (mouse/human MPO), cytokine release assays (MSD),

insulin secretion assays, Cyp induction assays (rat liver and human

hepatocytes using TaqMan).

. Managed and coordinated on-site blood donor program.

. Updated and wrote experimental protocols for Core Assay.

. Coordinated with RDI to develop and implement new templates for

Activity Base to analyze data.

ViroLogics, Inc (Monogram Biosciences) - South San Francisco, CA

2005

Clinical Laboratory Technician

. Conducted clinical accessioning work as part of the Accessioning

Department. Completed range of activities including logging test codes,

labeling, aliquot samples, aspiration of plasma, and lysis of plasma.

Rigel Pharmaceuticals, Inc - South San Francisco, CA

2005

Research Associate

. Performed cloning and gene construction, involving plasmid DNA

isolation, PCR insert screening, gel electrophoresis of DNA, gel

purification, enzyme digestion, ligation to vector, transformation,

mini-preps/maxi-preps, and sequence data analysis as part of the

Molecular Biology group.

Eun Ok Kim

Page 2

Strand and Seaborn - San Francisco, CA

2004

Legal Assistant

. Composed legal forms and documents for naturalization, permanent

residency, visa, and other immigration cases.

. Translated Korean-English (written, oral)

UC Davis Graduate Studies - Davis, CA

2001-2004

Fellowship Coordinator Assistant

. Conducted bookkeeping of graduate student funds - searched for funds,

updated and maintained internal database, advertised availability of

the fund, and analyzed database for correct distribution of Fund.

UC Davis Department of Medical Rheumatology - Davis, CA

2002-2003

Laboratory Assistant

. Assisted experiments in a cell biology laboratory, using procedures

and analysis including PCR, Gel electrophoresis, Western Blot,

Centrifugation and BLAST search for DNA and protein sequence analysis.

EDUCATION

University of California, Davis, B.S. Cell Biology, Minor Economics

2004

PUBLICATIONS

Comparative analysis of Raf inhibition versus MEK inhibition in Ras driven

tumor cell lines, Cutler R.E. Jr., B. Garrick, E.O. Kim, L. Goon, P. Yu, S.

H. Johnston, T. S. Heuer, 2007 AACR Annual Meeting. Los Angeles CA. April

2007.

Characterization of the target profile of XL228, a multi-targeted protein

kinase inhibitor in Phase 1 clinical development, Douglas O. Clary, Michael

M. Ollmann, Scott Detmer, Karen Fitzgerald, Ross Francis, Eun Ok Kim,

Carolyn D. Britten, Herbert I. Hurwitz, David C. Smith, 2009 EORTC Meeting.

Boston MA. November 2009.

Contact this candidate